These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3549597)

  • 1. A study of the drop-outs in psychopharmacological research with bulimics.
    Margittai KJ; Blouin A; Pérez E
    Int J Psychiatry Med; 1986-1987; 16(4):297-304. PubMed ID: 3549597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bulimia: independence of antibulimic and antidepressant properties of desipramine.
    Blouin J; Blouin A; Perez E; Barlow J
    Can J Psychiatry; 1989 Feb; 34(1):24-9. PubMed ID: 2647270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bulimia with desipramine: a double-blind crossover study.
    Barlow J; Blouin J; Blouin A; Perez E
    Can J Psychiatry; 1988 Mar; 33(2):129-33. PubMed ID: 3284630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drop-out and failure to engage in individual outpatient cognitive behavior therapy for bulimic disorders.
    Waller G
    Int J Eat Disord; 1997 Jul; 22(1):35-41. PubMed ID: 9140733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bulimia with fenfluramine and desipramine.
    Blouin AG; Blouin JH; Perez EL; Bushnik T; Zuro C; Mulder E
    J Clin Psychopharmacol; 1988 Aug; 8(4):261-9. PubMed ID: 3062043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology.
    Fichter MM; Krüger R; Rief W; Holland R; Döhne J
    J Clin Psychopharmacol; 1996 Feb; 16(1):9-18. PubMed ID: 8834413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study.
    McCann UD; Agras WS
    Am J Psychiatry; 1990 Nov; 147(11):1509-13. PubMed ID: 2221164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa.
    Walsh BT; Hadigan CM; Wong LM
    J Clin Psychopharmacol; 1992 Jun; 12(3):163-8. PubMed ID: 1629381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa.
    Leitenberg H; Rosen JC; Wolf J; Vara LS; Detzer MJ; Srebnik D
    Behav Res Ther; 1994 Jan; 32(1):37-45. PubMed ID: 8135721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bulimia with bupropion: a multicenter controlled trial.
    Horne RL; Ferguson JM; Pope HG; Hudson JI; Lineberry CG; Ascher J; Cato A
    J Clin Psychiatry; 1988 Jul; 49(7):262-6. PubMed ID: 3134343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dropout from brief psychotherapy within a combination treatment in bulimia nervosa: role of personality and anger.
    Fassino S; Abbate-Daga G; Pierò A; Leombruni P; Rovera GG
    Psychother Psychosom; 2003; 72(4):203-10. PubMed ID: 12792125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of antidepressant treatment for bulimia nervosa.
    Walsh BT; Hadigan CM; Devlin MJ; Gladis M; Roose SP
    Am J Psychiatry; 1991 Sep; 148(9):1206-12. PubMed ID: 1882999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac patients who completed a longitudinal psychosocial study had a different clinical and psychosocial baseline profile than patients who dropped out prematurely.
    Damen NL; Versteeg H; Serruys PW; van Geuns RJ; van Domburg RT; Pedersen SS; Boersma E
    Eur J Prev Cardiol; 2015 Feb; 22(2):196-9. PubMed ID: 24065741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why is attendance variable at groups for women with bulimia nervosa? The role of eating psychopathology and other characteristics.
    McKisack C; Waller G
    Int J Eat Disord; 1996 Sep; 20(2):205-9. PubMed ID: 8863074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-image and treatment drop-out in eating disorders.
    Björck C; Björk T; Clinton D; Sohlberg S; Norring C
    Psychol Psychother; 2008 Mar; 81(Pt 1):95-104. PubMed ID: 17631699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of depression to dissociation in patients with bulimia nervosa.
    Greenes D; Fava M; Cioffi J; Herzog DB
    J Psychiatr Res; 1993; 27(2):133-7. PubMed ID: 8366464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa.
    Agras WS; Rossiter EM; Arnow B; Telch CF; Raeburn SD; Bruce B; Koran LM
    J Clin Psychiatry; 1994 May; 55(5):179-83. PubMed ID: 8071266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between early and late drop-outs from treatment for obsessive-compulsive disorder.
    Aderka IM; Anholt GE; van Balkom AJ; Smit JH; Hermesh H; Hofmann SG; van Oppen P
    J Anxiety Disord; 2011 Oct; 25(7):918-23. PubMed ID: 21664103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa.
    Mitchell JE; Pyle RL; Eckert ED; Hatsukami D; Pomeroy C; Zimmerman R
    J Clin Psychopharmacol; 1989 Aug; 9(4):291-3. PubMed ID: 2671061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial.
    Sonawalla SB; Farabaugh AH; Leslie VM; Pava JA; Matthews JD; Fava M
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):415-9. PubMed ID: 11999889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.